Skip to main content

Quest Diagnostics diluted shares

  • DGX · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$259.60−0.02%Close 13 Nov 2026 · Market value $28.70B

Quest Diagnostics's diluted shares was 113M shares for fiscal year 2025 (the twelve months to 31 Dec 2025), unchanged from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was 112M shares, down 0.9% from a year earlier.

From Quest Diagnostics's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 23 Oct 2026.

Fiscal 2025
113M
0.0%
Q3 FY2026
112M
−0.9% on a year
Growth over 9 years
−2.5%
a year, FY 2016–FY 2025

Diluted shares by fiscal year

142MFY 2016140MFY 2017−1.4%139MFY 2018−0.7%136MFY 2019−2.2%136MFY 20200.0%128MFY 2021−5.9%118MFY 2022−7.8%113MFY 2023−4.2%113MFY 20240.0%113MFY 20250.0%

Change on the year before, under each year. From FY 2016 to FY 2025, Quest Diagnostics's diluted shares went from 142M shares to 113M shares, a compound annual change of −2.5%; the highest was 142M shares in FY 2016.

Quest Diagnostics diluted shares, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Diluted shares142M140M139M136M136M128M118M113M113M113M
Period end31 Dec 201631 Dec 201731 Dec 201831 Dec 201931 Dec 202031 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Diluted shares by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Quest Diagnostics diluted shares, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Diluted shares115M113M113M113M114M112M112M112M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How diluted shares is measured

Diluted shares is the weighted average number of shares outstanding in the period, counting the shares that options, warrants and convertible securities could add; it is the count earnings per share is divided by. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Quest Diagnostics's other figures

Diluted shares of comparable companies

Everything on DGX, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.